It can be challenging to decide which evidence synthesis software to choose when doing a systematic review. This article discusses some of the important questions to consider in relation to the chosen method and synthesis approach. Software can support researchers in a range of ways. Here, a range of review conditions and software solutions. For example, facilitating contemporaneous collaboration across time and geographical space; in-built bias assessment tools; and line-by-line coding for qualitative textual analysis. EPPI-Reviewer is a review software for research synthesis managed by the EPPI-centre,
Introduction: purpose of software?
There are an increasing number of ways available to manage data for reviews. So which one should you opt for when conducting a systematic review? This article highlights a number of factors useful to consider. EPPI-Reviewer is used as an example to illustrate some of these considerations in relation to the type of review and chosen approach.
Questions you might consider include: What is your budget and how much does the software cost? Requirements for review software can vary depending on how many individuals are involved in the review. A review team may be based in the same institution or include a collaboration across disperse geographical areas or even time zones. The team will need to consider how they organise the workload of, for example, screening, and whether a static repository-type function is sufficient or requires an up-todate and iterative platform. Some reviews use a set of searches conducted at one moment in time, whereas others are iterative, on-going or 'live', requiring a more dynamic form of software. Researchers might choose to use a software system for screening only, while others prefer to continue use of the same software for synthesis. Systematic review approaches vary from descriptive mapping to in-depth analysis. Some researchers may therefore simply wish to upload, collate and categorise references. Others, however, may need to conduct complex analyses of relationships between various elements of documents within the software programme.
User experience: EPPI-Reviewer
This next section describes some of the features of one software example: EPPI-Reviewer. This has a number of features, which meet a range of needs when conducting reviews. EPPI-Reviewer is a cloud-based systematic review platform which supports a range of reviews from quantitative meta-analysis to qualitative meta-ethnography. It contains features to categorise data and enable reviewers to keep track of decision-making pathways throughout the systematic review process. Like Covidence, it is widely used internationally and is used by both Cochrane and Campbell Collaborations. EPPI-Reviewer has been used for thousands of reviews across numerous topics including health, social care, education, criminology, international development and climate change.
Reviewers can begin by uploading text files containing bibliographic records and by searching PubMed directly from within the software. They can then screen the records for eligibility based on their titles and abstracts and, later, on full texts (which can be uploaded into the system too). The user interface is clear and enables contemporaneous collaboration across institutions (eg, during double screening). Researchers can choose from a number of prebuilt risk of bias and data extraction tools, or
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of PDF files and the ability to create reports of text in customised formats. A range of options for statistical meta-analysis are also available from integration with the 'R' statistical software which supports standard meta-analysis with a range of models and extensions including meta-regression and network meta-analysis.
The EPPI-Reviewer system includes automation technologies-including text mining and machine learning-to make the reviewing process more efficient. These include 'active learning' for citation screening, where the software 'learns' to apply your inclusion/exclusion criteria as you screen, which can make the process of study identification much more efficient. 1 It also has machine learning classifiers for identifying randomised controlled trials, systematic reviews and economic evaluations, and allows reviewers to build their own classifiers from their own data. EPPI-Reviewer has been adopted by National Institute for Health and Care Excellence (NICE) as its core evidence synthesis platform and the EPPI-Centre and NICE are currently collaborating on developing the next version of EPPI-Reviewer which is focused on streamlining workflow in a new web-based user interface and aims to support 'living' reviews and guidelines through the 'surveillance' of new research as it is published. 2 With this in mind, it carries out daily updates of new and updated material on PubMed. Then, using a mixture of machine learning and traditional information retrieval technologies, it identifies the type of research each new publication describes and seeks to identify which review/domain/ guideline it might be relevant for. EPPI-Reviewer in its current form already supports collaboration during a single review, but will contribute further to the evidence curation process with the new Version 5. This supports data sharing and re-use, aiming to reduce the considerable duplication of effort across the global systematic review community. Version 5 will also be released as open source software, again to foster collaborative efforts, though the EPPI-Centre will continue to offer the software as a cloud-based service. The software is offered via a subscription with a 1-month (extendible) trial available and volume discounts for 'site licences' . It is free to use for Cochrane and Campbell reviews.
Conclusion
Evidence synthesis is central to the integration of evidence and practice. While the amount of available knowledge and research is constantly increasing, the ways in which software can support the focus and relevance of data identification are also fast developing. Software advances are maximising the opportunities for the production of relevant and timely reviews. There will never be a 'one size fits all' approach and it is important to consider what functions you require of a software platform before starting your systematic review. Evidence synthesis approaches are evolving fast and as the relationships between evidence and practice strengthen, the demand for more iterative and 'live' approaches is likely to grow. The rigour and complexity of synthesis methods is also expanding, with an increasing range of mixed methods and in-depth approaches used. EPPI-Reviewer is one example of a platform which has evolved with these increasing challenges and provides a wide range of user-friendly and adaptable features to support researchers in this field.
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